DIN 02308509 — VECTIBIX 400 MG
VECTIBIX is a solution of Panitumumab marketed by AMGEN CANADA INC. The full Panitumumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02308509
- Brand name
- VECTIBIX
- Active ingredient
- Panitumumab
- Strength
- 400 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Epidermal growth factor receptor (EGFR) inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Panitumumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02308487 | VECTIBIX | 100 MG | SOLUTION | AMGEN CANADA INC | MARKETED |